The agency also emphasised that the medication alone would not reverse the trend in obesity, which it recognised as a complex, chronic disease and a major driver of non-communicable diseases, including cardiovascular disease, type-2 diabetes and some types of cancer
Whether your stomach is full or empty when you inject has no effect on how the medication is absorbed
Clinical assessments reveal that patients report losing an average of 15% of their body weight
Two years after surgery, semaglutide 2.4 mg was given weekly, which resulted in a weight loss of more than 30 kg (25%) and BMI reduction from 46.9 to 35.1 kg/m 2 after 6 months of treatment
La principal ventaja adicional de los GLP-1 es la prdida de peso
Today, there are GLP-1 drugs made for diabetic patients (e.g., Ozempic and Mounjaro) and GLP-1s intended for weight loss patients (e.g., Wegovy and Zepbound)